# Lovesac Co: financial statements, quarterly

LOVE · Nasdaq · CIK 1701758 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 4

Pages: [Overview](/companies/love.md) · [Financials](/companies/love/financials.md) · [Filings](/companies/love/filings.md) · [Insiders](/companies/love/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/love/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-29) | Q4 FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q4 FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q4 FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [154](/filings/0001628280-24-050870.md) | [251 d](/filings/0001628280-26-022929.md) | [133](/filings/0001628280-25-030861.md) | [157](/filings/0001701758-25-000016.md) | [150](/filings/0001628280-25-056423.md) | [241 d](/filings/0001628280-26-022929.md) | [138](/filings/0001628280-26-042366.md) | [161](/filings/0001628280-26-061220.md) | [150](/filings/0001628280-25-056423.md) | [248 d](/filings/0001628280-26-022929.md) | [138](/filings/0001628280-26-042366.md) | [161](/filings/0001628280-26-061220.md) |
| Cost of revenue | $m | [65.6](/filings/0001628280-24-050870.md) | [101 d](/filings/0001628280-26-022929.md) | [60.6](/filings/0001628280-25-030861.md) | [64.2](/filings/0001701758-25-000016.md) | [62.3](/filings/0001628280-25-056423.md) | [95.7 d](/filings/0001628280-26-022929.md) | [64.0](/filings/0001628280-26-042366.md) | [69.9](/filings/0001628280-26-061220.md) | [65.9](/filings/0001628280-25-056423.md) | [104 d](/filings/0001628280-26-022929.md) | [66.2](/filings/0001628280-26-042366.md) | [51.0](/filings/0001628280-26-061220.md) |
| Gross profit | $m | [88.4](/filings/0001628280-24-050870.md) | [150 d](/filings/0001628280-26-022929.md) | [72.0](/filings/0001628280-25-030861.md) | [92.4](/filings/0001701758-25-000016.md) | [87.6](/filings/0001628280-25-056423.md) | [146 d](/filings/0001628280-26-022929.md) | [74.4](/filings/0001628280-26-042366.md) | [90.6](/filings/0001628280-26-061220.md) | [84.2](/filings/0001628280-25-056423.md) | [144 d](/filings/0001628280-26-022929.md) | [72.0](/filings/0001628280-26-042366.md) | [110](/filings/0001628280-26-061220.md) |
| Research and development | $m | not reported | not reported | [2.1](/filings/0001628280-25-030861.md) | [2.4](/filings/0001701758-25-000016.md) | [2.3](/filings/0001628280-25-056423.md) | [1.6 d](/filings/0001628280-26-022929.md) | [2.2](/filings/0001628280-26-042366.md) | [2.1](/filings/0001628280-26-061220.md) | [2.3](/filings/0001628280-25-056423.md) | [0.4 d](/filings/0001628280-26-022929.md) | [2.1](/filings/0001628280-26-042366.md) | [1.8](/filings/0001628280-26-061220.md) |
| Selling, general and administrative | $m | [67.6](/filings/0001628280-24-050870.md) | [76.3 d](/filings/0001628280-26-022929.md) | [68.4](/filings/0001628280-25-030861.md) | [73.7](/filings/0001701758-25-000016.md) | [71.7](/filings/0001628280-25-056423.md) | [67.6 d](/filings/0001628280-26-022929.md) | [67.1](/filings/0001628280-26-042366.md) | [72.1](/filings/0001628280-26-061220.md) | [75.0](/filings/0001628280-25-056423.md) | [69.8 d](/filings/0001628280-26-022929.md) | [68.6](/filings/0001628280-26-042366.md) | [72.3](/filings/0001628280-26-061220.md) |
| Operating income | $m | [(3.6)](/filings/0001628280-24-050870.md) | [40.4 d](/filings/0001628280-26-022929.md) | [(17.9)](/filings/0001628280-25-030861.md) | [(8.4)](/filings/0001701758-25-000016.md) | [(7.7)](/filings/0001628280-25-056423.md) | [47.6 d](/filings/0001628280-26-022929.md) | [(15.0)](/filings/0001628280-26-042366.md) | [(8.8)](/filings/0001628280-26-061220.md) | [(15.8)](/filings/0001628280-25-056423.md) | [44.9 d](/filings/0001628280-26-022929.md) | [(17.4)](/filings/0001628280-26-042366.md) | [10.9](/filings/0001628280-26-061220.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.0)](/filings/0001628280-24-050870.md) | [10.2 d](/filings/0001628280-26-022929.md) | [(4.2)](/filings/0001628280-25-030861.md) | [(1.8)](/filings/0001701758-25-000016.md) | [(2.1)](/filings/0001628280-25-056423.md) | [13.0 d](/filings/0001628280-26-022929.md) | [(3.8)](/filings/0001628280-26-042366.md) | [(2.1)](/filings/0001628280-26-061220.md) | [(5.0)](/filings/0001628280-25-056423.md) | [13.5 d](/filings/0001628280-26-022929.md) | [(5.6)](/filings/0001628280-26-042366.md) | [4.7](/filings/0001628280-26-061220.md) |
| Net income | $m | [(2.3)](/filings/0001628280-24-050870.md) | [31.0 d](/filings/0001628280-26-022929.md) | [(13.0)](/filings/0001628280-25-030861.md) | [(5.9)](/filings/0001701758-25-000016.md) | [(4.9)](/filings/0001628280-25-056423.md) | [35.3 d](/filings/0001628280-26-022929.md) | [(10.8)](/filings/0001628280-26-042366.md) | [(6.7)](/filings/0001628280-26-061220.md) | [(10.6)](/filings/0001628280-25-056423.md) | [32.1 d](/filings/0001628280-26-022929.md) | [(11.1)](/filings/0001628280-26-042366.md) | [7.4](/filings/0001628280-26-061220.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001628280-24-050870.md) | not reported | [(0.83)](/filings/0001628280-25-030861.md) | [(0.38)](/filings/0001701758-25-000016.md) | [(0.32)](/filings/0001628280-25-056423.md) | not reported | [(0.73)](/filings/0001628280-26-042366.md) | [(0.45)](/filings/0001628280-26-061220.md) | [(0.72)](/filings/0001628280-25-056423.md) | not reported | [(0.76)](/filings/0001628280-26-042366.md) | [0.51](/filings/0001628280-26-061220.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001628280-24-050870.md) | not reported | [(0.83)](/filings/0001628280-25-030861.md) | [(0.38)](/filings/0001701758-25-000016.md) | [(0.32)](/filings/0001628280-25-056423.md) | not reported | [(0.73)](/filings/0001628280-26-042366.md) | [(0.45)](/filings/0001628280-26-061220.md) | [(0.72)](/filings/0001628280-25-056423.md) | not reported | [(0.76)](/filings/0001628280-26-042366.md) | [0.51](/filings/0001628280-26-061220.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-29) | FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.7](/filings/0001628280-23-040881.md) | [87.0](/filings/0001628280-25-017241.md) | [72.4](/filings/0001628280-24-028040.md) | [72.1](/filings/0001628280-24-040192.md) | [61.7](/filings/0001628280-24-050870.md) | [83.7](/filings/0001628280-26-022929.md) | [26.9](/filings/0001628280-25-030861.md) | [34.2](/filings/0001701758-25-000016.md) | [23.7](/filings/0001628280-25-056423.md) | [102](/filings/0001628280-26-061220.md) | [57.0](/filings/0001628280-26-042366.md) | [68.8](/filings/0001628280-26-061220.md) |
| Current assets | $m | [184](/filings/0001628280-23-040881.md) | [214](/filings/0001628280-25-017241.md) | [191](/filings/0001628280-24-028040.md) | [194](/filings/0001628280-24-040192.md) | [210](/filings/0001628280-24-050870.md) | [247](/filings/0001628280-26-022929.md) | [181](/filings/0001628280-25-030861.md) | [190](/filings/0001701758-25-000016.md) | [186](/filings/0001628280-25-056423.md) | [237](/filings/0001628280-26-061220.md) | [199](/filings/0001628280-26-042366.md) | [239](/filings/0001628280-26-061220.md) |
| Total assets | $m | [436](/filings/0001628280-23-040881.md) | [482](/filings/0001628280-25-017241.md) | [477](/filings/0001628280-24-028040.md) | [481](/filings/0001628280-24-040192.md) | [500](/filings/0001628280-24-050870.md) | [532](/filings/0001628280-26-022929.md) | [484](/filings/0001628280-25-030861.md) | [494](/filings/0001701758-25-000016.md) | [496](/filings/0001628280-25-056423.md) | [535](/filings/0001628280-26-061220.md) | [501](/filings/0001628280-26-042366.md) | [539](/filings/0001628280-26-061220.md) |
| Current liabilities | $m | [106](/filings/0001628280-23-040881.md) | [106](/filings/0001628280-25-017241.md) | [106](/filings/0001628280-24-028040.md) | [115](/filings/0001628280-24-040192.md) | [141](/filings/0001628280-24-050870.md) | [155](/filings/0001628280-26-022929.md) | [113](/filings/0001628280-25-030861.md) | [125](/filings/0001701758-25-000016.md) | [137](/filings/0001628280-25-056423.md) | [147](/filings/0001628280-26-061220.md) | [128](/filings/0001628280-26-042366.md) | [162](/filings/0001628280-26-061220.md) |
| Total liabilities | $m | [251](/filings/0001628280-23-040881.md) | [265](/filings/0001628280-25-017241.md) | [272](/filings/0001628280-24-028040.md) | [279](/filings/0001628280-24-040192.md) | [303](/filings/0001628280-24-050870.md) | [316](/filings/0001628280-26-022929.md) | [283](/filings/0001628280-25-030861.md) | [296](/filings/0001701758-25-000016.md) | [306](/filings/0001628280-25-056423.md) | [316](/filings/0001628280-26-061220.md) | [295](/filings/0001628280-26-042366.md) | [329](/filings/0001628280-26-061220.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [186](/filings/0001628280-24-050870.md) | [217](/filings/0001628280-26-022929.md) | [205](/filings/0001701758-25-000016.md) | [202](/filings/0001628280-25-056423.md) | [196](/filings/0001628280-25-056423.md) | [216](/filings/0001628280-26-061220.md) | [201](/filings/0001628280-26-061220.md) | [197](/filings/0001628280-26-061220.md) | [189](/filings/0001628280-25-056423.md) | [219](/filings/0001628280-26-061220.md) | [206](/filings/0001628280-26-061220.md) | [210](/filings/0001628280-26-061220.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-29) | Q4 FY2024 (2024-02-04) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q4 FY2025 (2025-02-02) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q4 FY2026 (2026-02-01) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.2) d](/filings/0001628280-24-050870.md) | [56.3 d](/filings/0001628280-26-022929.md) | [(7.0)](/filings/0001628280-25-030861.md) | [6.2 d](/filings/0001701758-25-000016.md) | [(4.2) d](/filings/0001628280-25-056423.md) | [44.0 d](/filings/0001628280-26-022929.md) | [(41.4)](/filings/0001628280-26-042366.md) | [12.2 d](/filings/0001628280-26-061220.md) | [(4.9) d](/filings/0001628280-25-056423.md) | [83.4 d](/filings/0001628280-26-022929.md) | [(35.4)](/filings/0001628280-26-042366.md) | [23.9 d](/filings/0001628280-26-061220.md) |
| Capital expenditure | $m | [9.6 d](/filings/0001628280-24-050870.md) | [6.8 d](/filings/0001628280-26-022929.md) | [7.3](/filings/0001628280-25-030861.md) | [6.1 d](/filings/0001701758-25-000016.md) | [2.4 d](/filings/0001628280-25-056423.md) | [5.3 d](/filings/0001628280-26-022929.md) | [8.6](/filings/0001628280-26-042366.md) | [4.3 d](/filings/0001628280-26-061220.md) | [5.3 d](/filings/0001628280-25-056423.md) | [4.9 d](/filings/0001628280-26-022929.md) | [5.0](/filings/0001628280-26-042366.md) | [6.6 d](/filings/0001628280-26-061220.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001628280-26-022929.md) | [0.0](/filings/0001628280-25-030861.md) | [0.0 d](/filings/0001701758-25-000016.md) | [3.4 d](/filings/0001628280-25-056423.md) | [16.5 d](/filings/0001628280-26-022929.md) | [6.0](/filings/0001628280-26-042366.md) | [0.0 d](/filings/0001628280-26-061220.md) | [0.0 d](/filings/0001628280-25-056423.md) | [0.0 d](/filings/0001628280-26-022929.md) | [2.4](/filings/0001628280-26-042366.md) | [4.9 d](/filings/0001628280-26-061220.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-30) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-30) | Q3 FY2024 (2023-10-29) | Q1 FY2025 (2024-05-05) | Q2 FY2025 (2024-08-04) | Q3 FY2025 (2024-11-03) | Q1 FY2026 (2025-05-04) | Q2 FY2026 (2025-08-03) | Q3 FY2026 (2025-11-02) | Q1 FY2027 (2026-05-03) | Q2 FY2027 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.2](/filings/0001628280-23-040881.md) | [15.2](/filings/0001628280-24-028040.md) | [15.4](/filings/0001628280-24-040192.md) | [15.5](/filings/0001628280-24-050870.md) | [15.5](/filings/0001628280-25-030861.md) | [15.6](/filings/0001701758-25-000016.md) | [15.6](/filings/0001628280-25-056423.md) | [14.8](/filings/0001628280-26-042366.md) | [14.6](/filings/0001628280-26-061220.md) | [14.7](/filings/0001628280-25-056423.md) | [14.7](/filings/0001628280-26-042366.md) | [14.7](/filings/0001628280-26-061220.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,423,433 at 2026-09-07, from the cover of the [10-Q filed 2026-09-10](/filings/0001628280-26-061220.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.